Modalis Therapeutics
Emerging biotech company that develops therapeutics using CRISPR based technology.
Launch date
Employees
Market cap
€27.4m
Enterprise valuation
€20m (Public information from Sep 2024)
Share price
JPY103 4883.T
Cambridge Massachusetts (HQ), Tokyo Japan (founding location)
Authorizing premium user...